R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients.

about

R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients.

Item

http://www.wikidata.org/entity/Q47982342

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

R-CHOP

@nl

R-CHOP(-like) treatment of dif ...... center study of 111 patients.

@en

type

Item

label

R-CHOP

@nl

R-CHOP(-like) treatment of dif ...... center study of 111 patients.

@en

prefLabel

R-CHOP

@nl

R-CHOP(-like) treatment of dif ...... center study of 111 patients.

@en

P1476

R-CHOP(-like) treatment of dif ...... center study of 111 patients.

@en

P2093

Anders Krog Vistisen

http://www.w3.org/2001/XMLSchema#string

Kasper Lindblad Nielsen

http://www.w3.org/2001/XMLSchema#string

Lasse Hjort Jakobsen

http://www.w3.org/2001/XMLSchema#string

Mette Østergaard Poulsen

http://www.w3.org/2001/XMLSchema#string

Nitesh Shekhrajka

http://www.w3.org/2001/XMLSchema#string

Pernille Svendsen

http://www.w3.org/2001/XMLSchema#string

Peter Svenssen Munksgaard

http://www.w3.org/2001/XMLSchema#string

Peter Vestergaard

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

Osteoporosis due to cancer treatment: pathogenesis and management.

Use of oral corticosteroids and risk of fractures.

Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis.

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.

P304

1105-1113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2016.1233543

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Bøgsted

Tarec Christoffer El-Galaly

Hans Erik Johnsen

Jens B. Frøkjær

Marianne T Severinsen

Paw Jensen

P577

2016-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27736260

http://www.w3.org/2001/XMLSchema#string